Richard Moyle

Overview: What every practitioner needs to know Are you sure your patient has allergic bronchopulmonary aspergillosis? What are the typical findings for this disease? Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease due to bronchial colonization by Aspergillus fumigatus that occurs in susceptible patients with asthma and cystic fibrosis (CF). ABPA affects approximately 1-2%…

At a Glance Mantle cell lymphoma is a small B-cell lymphoma that is clinically more aggressive than other small B-cell non-Hodgkin lymphomas. It commonly presents at a higher stage, including bone marrow and peripheral blood involvement. It is a disease of adults and is more common in men. What Tests Should I Request to Confirm…

Lyme Disease I. General description. Lyme disease is the most common tick-borne illness in North America and Europe. In the United States, Lyme disease is caused by the spirochete Borrelia burgdorferi, transmitted mostly by Ixodes scapularis (deer ticks) in the eastern and northern mid-western states and by Ixodes pacificus ticks in the western states. In…

Allergic bronchopulmonary aspergillosis Allergic bronchopulmonary aspergillosis (ABPA) is a type of hypersensitivity lung disease caused by an allergic response to Aspergillus fumigatus. Aspergillus lives ubiquitously in the environment as thermotolerant spore forming fungi, found in moisture rich areas such as ceilings, compost piles and household produce and bread. Of the 250 known species of Aspergillus,…

Peripheral T cell lymphoma, unspecified What every physician needs to know: Peripheral T cell lymphoma (PTCL) is an aggressive disease that most commonly presents in patients over the age of 60 with rapidly progressive lymphadenopathy, fevers, night sweats, and weight loss. Extranodal involvement, particularly of the skin and bone marrow, is common. Occasionally PTCL can…

1. Description of the problem What every clinician needs to know While the incidence of peptic ulcer disease (PUD) has dropped significantly, it still is a common problem. Over the past 25 years, with the advent of H2-blocking agents and proton-pump inhibitors and the diagnosis and treatment of H. pylori infections, PUD has been changed…

My patient read on the internet that there is a new drug for osteoporosis called abaloparatide. Is it available? What does it do? Abaloparatide is a new drug being considered by the FDA for the treatment of osteoporosis. Like teriparatide (Forteo), it is an anabolic agent, one that actually builds bone. So, it is very…